IBIO Bathi mangsa ngarep iBio Inc

iBio Corp - logo grafis emiten IBIO

iBio, Inc. (IBIO) is diversifying its operations by combining the development of proprietary drugs with AI services for partners. The company has shifted its strategic direction, replacing manufacturing plants with cloud-based antibody design. Synergy with the biotech sector via RubrYc licenses is accelerating the discovery of oncology drugs. The profit change forecast demonstrates operational return dynamics, where the current status equals , allowing for an assessment of the asset's potential on the chart.

IBIO: Prakiraan bathi perusahaan iBio, Inc. 04.07.2022 - 16.11.2026

Rincian analitis perusahaan iBio, Inc.

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:IBIO, iBio Corp
Barang utama iBio Corporation

This indicator reflects the expected net profit volume, adjusted for operating expenses and market noise. Professionals utilize this parameter to determine the fundamental value of a business through discounted cash flow analysis. By analyzing the company's projected net income, an investor assesses the real growth momentum of the enterprise. For iBio, Inc. (IBIO), such dynamics confirm the commercial value of AI-driven antibody development platforms. Patent protection of these technologies ensures a steady stream of royalties from pharma behemoths for years to come.

Perusahaan pesaing

ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (protagonist-inc.com)|Prakiraan bathi perusahaan immunovant.com (IMVT)|KNSA - Bathi sing dikarepake|Grifols SA (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Inc. (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep biocryst.com|Bathi sing dikarepake Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Bathi resik sing dikarepake|TRML: Bathi mangsa ngarep|Bathi forward PGEN|PHAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Nektar Therapeutics Inc (NKTR)|Bathi mangsa ngarep UPB|Prakiraan bathi resik ZBIO (Zenas Biopharma, Inc.)|Bathi mangsa ngarep IMNM (Immunome Bio)|Prakiraan bathi perusahaan Gossamer Bio, Inc.|Proyeksi bathi mangsa ngarep KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Bathi resik sing dikarepake|PVLA - Bathi sing dikarepake|SVRA - Proyeksi bathi mangsa ngarep|Rigel Pharmaceuticals Inc (RIGL) - Bathi sing dikarepake|ANAB - Prakiraan bathi perusahaan|Bathi mangsa ngarep ATXS|ENGN: Penghasilan resik sing dikarepake|Bathi sing dikarepake RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ACRS (Aclaris Therapeutics)|Penghasilan resik sing dikarepake KYTX|Tiziana Life Sciences - Proyeksi bathi mangsa ngarep|CABA: Bathi sing dikarepake|VTYX: Proyeksi bathi mangsa ngarep|THTX (Theratechnologies, Inc) - Bathi sing dikarepake|AVTX (Avalo Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Eledon Pharmaceuticals|Bathi sing dikarepake Agenus Inc. (AGEN)|Bathi mangsa ngarep Climb Bio Inc. CLYM|Proyeksi bathi mangsa ngarep ZURA (Zura Bio Ltd)|ATYR - Bathi mangsa ngarep|ADAG - Bathi sing dikarepake|IMA - Proyeksi bathi mangsa ngarep|STTK: Proyeksi bathi mangsa ngarep|Equillium Bio (EQ) - Proyeksi bathi mangsa ngarep|CNTB (connectbiopharm.com) - Proyeksi bathi mangsa ngarep|IMUX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ATRA|Proyeksi bathi mangsa ngarep InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Bathi forward|Proyeksi bathi mangsa ngarep adicetbio.com ACET|Celularity - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Bathi mangsa ngarep|Bathi forward KZR (Kezar Life Sciences)|Bathi sing dikarepake SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Bathi forward|Bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd.)|Bathi mangsa ngarep Q32 Bio Inc QTTB|Bathi sing dikarepake geovax.com GOVX|Proyeksi bathi mangsa ngarep edesabiotech.com EDSA|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep